Vitro Diagnostics, Inc. (OTCBB: VODG), dba Vitro Biopharma, announced advances in its adult stem cell products and technology with application to cell-based therapy of cancer. With the passing of Senator Edward Kennedy from brain cancer, we are reminded of such aggressive cancers without effective treatment.
Cancer stem cells are thought to generate cancerous tumors, and while some of these tumor cells are destroyed by chemotherapy and radiation, cancer stem cells resist these treatments causing recurrences and metastasis of cancer following standard therapy. For example, glioblastoma tumors underlying Senator Kennedy’s brain cancer may arise from cancer stem cells that resist conventional treatments. Additional research shows that certain adult stem cells migrate to cancer stem cells and may be used to carry toxic agents to selectively eradicate cancer stem cells thereby providing novel cellular therapy specifically targeted to cancer-causing cells. Further development of stem cell therapy may allow treatment of presently untreatable cancer and also have more widespread applications to prevention and treatment of cancer.